21 May 2013
Keywords: akorn, signs, 10-year, supply, deal, cipla, usa-based
Article | 30 July 2007
USA-based Akorn has signed an exclusive drug development and supply agreement with Cipla, a leading Indian pharmaceutical company located in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 July 2007
20 May 2013
© 2013 thepharmaletter.com